Shilpa Medicare Current Share Price | Shilpa Medicare Stock Screener
SHILPAMED
Pharmaceuticals
Shilpa Medicare Current Stock Price Today
Live Share Price NSE
₹1021.10
▲
62.75 (6.55%)
Live Share Price BSE
₹1020.90
▲
63.50 (6.63%)
As of September 18, 2026, the live Shilpa Medicare share price (NSE: SHILPAMED) is ₹1,021.10 on NSE and ₹1,020.90 on BSE, up 6.55% from the previous close, with shares trading between ₹951.90 and ₹1,033.10 in today's trading session, and a 52-week range of ₹267.00–₹1,021.10.
Browse SHILPAMED financial statements to support your investment research.
Use the Shilpa Medicare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Shilpa Medicare Market Cap
₹18,798.35 Cr.
SHILPAMED P/E Ratio (TTM)
61.86
Shilpa Medicare P/B Ratio
7.10
EPS (TTM)
₹12.44
Dividend Yield
0.06%
Debt to Equity
0.25
SHILPAMED 52 Week High
₹1021.10
Shilpa Medicare 52 Week Low
₹267.00
Operating Margin
29.00%
Profit Margin
21.26%
SHILPAMED Revenue (TTM)
₹475.00
EBITDA
₹145.00
Net Income
₹101.00
Total Assets
₹3,706.00
Total Equity
₹2,591.00
Shilpa Medicare Current Share Price Chart
Track the current Shilpa Medicare share price and stock price with an interactive chart. Analyse SHILPAMED price trends, trading volume, historical performance, and volatility across different timeframes — the complete Shilpa Medicare stock quote in one place.
Shilpa Medicare Company Profile - Fundamental Screener
Screen Shilpa Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHILPAMED shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE790G01031
Shilpa Medicare Balance Sheet Screener
Screen SHILPAMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,706 | 3,311 | 3,093 | 2,904 | 2,876 | 2,632 | 1,989 | 1,610 | 1,499 | 1,472 |
| Current Assets | 1,110 | 985 | 877 | 770 | 887 | 903 | 624 | 545 | 672 | 730 |
| Fixed Assets | 1,593 | 1,418 | 1,385 | 1,368 | 1,342 | 1,111 | 650 | 558 | 534 | 492 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 266 | 273 | 600 | 345 | 453 | 561 | 257 | 167 | 154 | 251 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,591 | 2,364 | 1,800 | 1,774 | 1,811 | 1,468 | 1,322 | 1,190 | 1,080 | 984 |
| Share Capital | 20 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 2,572 | 2,353 | 1,800 | 1,775 | 1,814 | 1,471 | 1,321 | 1,189 | 1,077 | 979 |
Shilpa Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Shilpa Medicare income statement and profit fundamentals.
Analyze SHILPAMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shilpa Medicare share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 475 | 482 | 411 | 372 | 328 | 341 | 321 | 349 | 302 | 300 | 289 | 315 | 262 | 266 | 266 |
| Expenses | 330 | 317 | 309 | 262 | 231 | 282 | 239 | 258 | 223 | 222 | 222 | 255 | 214 | 227 | 231 |
| EBITDA | 145 | 165 | 102 | 110 | 97 | 59 | 82 | 91 | 80 | 79 | 67 | 60 | 48 | 39 | 34 |
| Operating Profit % | 29.00% | 27.00% | 25.00% | 29.00% | 28.00% | 15.00% | 25.00% | 25.00% | 24.00% | 24.00% | 23.00% | 19.00% | 18.00% | 14.00% | 12.00% |
| Depreciation | 35 | 31 | 30 | 30 | 29 | 29 | 29 | 28 | 27 | 27 | 27 | 28 | 27 | 26 | 24 |
| Interest | 12 | 14 | 11 | 16 | 19 | 15 | 12 | 26 | 24 | 24 | 26 | 23 | 18 | 18 | 18 |
| Profit Before Tax | 98 | 120 | 61 | 64 | 50 | 15 | 42 | 37 | 29 | 28 | 14 | 9 | 3 | -4 | -8 |
| Tax | -3 | 13 | 16 | 20 | 3 | 1 | 10 | 19 | 15 | 3 | 10 | 8 | 2 | 4 | -1 |
| Net Profit | 101 | 108 | 45 | 44 | 47 | 15 | 32 | 18 | 14 | 25 | 5 | 2 | 1 | -8 | -7 |
| EPS | 5.16 | 5.51 | 2.28 | 5.50 | 4.79 | 0.74 | 3.25 | 1.83 | 1.46 | 2.82 | 0.53 | 0.19 | 0.14 | -0.93 | -0.76 |
Shilpa Medicare Cash Flow Screener - Liquidity Fundamentals
Screen SHILPAMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 342 | 132 | 137 | 180 | 105 | 47 | 124 | 147 | 45 | 38 |
| Investing Activities | -339 | -198 | -171 | -232 | -286 | -404 | -290 | -196 | -10 | -257 |
| Financing Activities | 14 | 63 | 47 | 46 | 83 | 436 | 176 | 10 | -61 | 313 |
| Net Cash Flow | 17 | -3 | 13 | -7 | -98 | 79 | 10 | -40 | -26 | 93 |
Shilpa Medicare Shareholding Pattern Screener
See Shilpa Medicare shareholding pattern with promoter, FII, and DII holdings.
Check Shilpa Medicare promoter holding and ownership changes for SHILPAMED on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 40.13% | 40.13% | 40.13% | 44.23% | 44.23% | 44.23% | 44.23% | 44.33% |
| FII Holding | 11.38% | 11.08% | 10.97% | 10.92% | 11.20% | 10.97% | 9.90% | 9.58% |
| DII Holding | 8.05% | 8.58% | 8.33% | 7.67% | 7.46% | 7.55% | 8.27% | 8.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.67% | 27.70% | 27.80% | 23.34% | 23.21% | 24.43% | 24.40% | 23.94% |
| Other Holding | 12.76% | 12.51% | 12.76% | 13.84% | 13.90% | 12.83% | 13.21% | 13.96% |
| Shareholder Count | 60,926 | 53,410 | 53,799 | 52,065 | 48,636 | 50,108 | 49,034 | 42,784 |
Shilpa Medicare Share Dividend Screener - Share Yield Analysis
Check Shilpa Medicare dividend history with payout and yield data.
View Shilpa Medicare dividend details including ex-dates and amounts for SHILPAMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.60 | 0.06% |
| 2025-March | ₹1.00 | 0.29% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.10 | 0.96% |
| 2021-March | ₹1.10 | 0.55% |
| 2020-March | ₹1.10 | 0.66% |
| 2019-March | ₹1.00 | 0.82% |
| 2018-March | ₹0.70 | 0.41% |
| 2017-March | ₹0.60 | 0.26% |
Shilpa Medicare Stock Index Membership
See which indices include Shilpa Medicare stock.
Check SHILPAMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Shilpa Medicare Market Events Screener - Corporate Actions
Get Shilpa Medicare corporate actions including splits, bonuses, and buybacks.
Check Shilpa Medicare stock events that may affect SHILPAMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-11 | 2026-09-11 | Annual General Meeting | NA | 45.85% |
| 2026-09-04 | 2026-09-04 | Dividend | ₹ 0.60 /share | 101.23% |
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | 6.50% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 8.35% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 17.02% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 11.79% |
| 2025-10-03 | 2025-10-03 | Bonus | 1:1 | -5.18% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | -6.08% |
| 2025-09-17 | 2025-09-17 | Dividend | ₹ 1.00 /share | 5.73% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.33% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 10.39% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 5.08% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.95% |
| 2024-09-17 | 2024-09-17 | Annual General Meeting | NA | 26.59% |
| 2022-09-19 | 2022-09-20 | Dividend | ₹ 1.10 /share | -10.81% |
Shilpa Medicare Competitors Screener - Peer Comparison
Screen SHILPAMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Shilpa Medicare Company Announcements - News Screener
Screen SHILPAMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-19 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-17 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-17 | Initiation Of NCLT Order On FTF Pharma Private Limited A Wholly Owned Subsidiary Of Shilpa Medicare Limited. | - |
| 2026-08-19 | Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent /Depository Participants | - |
| 2026-08-18 | Response On The News Item Captioned Shilpa Medicare Recalls Over 27K Vials Of Chemotherapy Drug In US Published In The Online Edition Of The Economic Times On August 17 2026 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Reg. 34 (1) Annual Report. | - |
| 2026-08-13 | 39Th Annual General Meeting Notice | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-05 | Final Dividend For The FY 2025-26 | - |
| 2026-08-05 | Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026 | - |
| 2026-08-05 | Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30 June 2026 | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-29 | Board Meeting Intimation for Quarterly Financial Results | - |
| 2026-07-16 | Announcement under Regulation 30 (LODR)-Credit Rating | - |